<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Song Y</submitter><funding>the National Key Research and Development Program of China</funding><funding>the Military Logistics Research Project Health Special Project</funding><pagination>15406</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11224322</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(1)</volume><pubmed_abstract>Patients with multiple myeloma (MM) experience relapse and drug resistance; therefore, novel treatments are essential. Clotrimazole (CTZ) is a wide-spectrum antifungal drug with antitumor activity. However, CTZ's effects on MM are unclear. We investigated CTZ's effect on MM cell proliferation and apoptosis induction mechanisms. CTZ's effects on MM.1S, NCI- H929, KMS-11, and U266 cell growth were investigated using Cell Counting Kit-8 (CCK-8) assay. The apoptotic cell percentage was quantified with annexin V-fluorescein isothiocyanate/7-amino actinomycin D staining. Mitochondrial membrane potential (MMP) and cell cycle progression were evaluated. Reactive oxygen species (ROS) levels were measured via fluorescence microscopy. Expression of apoptosis-related and nuclear factor (NF)-κB signali</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>Clotrimazole inhibits growth of multiple myeloma cells in vitro via G0/G1 arrest and mitochondrial apoptosis.</pubmed_title><pmcid>PMC11224322</pmcid><funding_grant_id>NCRCG-PLAGH-20230010</funding_grant_id><funding_grant_id>2021YFC2701704</funding_grant_id><pubmed_authors>Lu X</pubmed_authors><pubmed_authors>Zhang H</pubmed_authors><pubmed_authors>Bo Y</pubmed_authors><pubmed_authors>Geng J</pubmed_authors><pubmed_authors>Chen H</pubmed_authors><pubmed_authors>Song Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Clotrimazole inhibits growth of multiple myeloma cells in vitro via G0/G1 arrest and mitochondrial apoptosis.</name><description>Patients with multiple myeloma (MM) experience relapse and drug resistance; therefore, novel treatments are essential. Clotrimazole (CTZ) is a wide-spectrum antifungal drug with antitumor activity. However, CTZ's effects on MM are unclear. We investigated CTZ's effect on MM cell proliferation and apoptosis induction mechanisms. CTZ's effects on MM.1S, NCI- H929, KMS-11, and U266 cell growth were investigated using Cell Counting Kit-8 (CCK-8) assay. The apoptotic cell percentage was quantified with annexin V-fluorescein isothiocyanate/7-amino actinomycin D staining. Mitochondrial membrane potential (MMP) and cell cycle progression were evaluated. Reactive oxygen species (ROS) levels were measured via fluorescence microscopy. Expression of apoptosis-related and nuclear factor (NF)-κB signali</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jul</publication><modification>2025-04-21T16:15:05.743Z</modification><creation>2025-04-21T16:15:05.743Z</creation></dates><accession>S-EPMC11224322</accession><cross_references><pubmed>38965397</pubmed><doi>10.1038/s41598-024-66367-5</doi></cross_references></HashMap>